Organic compounds -- part of the class 532-570 series inventions

20090275751 - 1,2-dihydropyridine compounds, manufacturing method thereof and use thereof: In the formula, Q indicates NH, O or S; and R1, R2, R3, R4 and R5 are the same as or different from each other and each indicates hydrogen atom, a halogen atom, a C1-6 alkyl group or a group represented by the formula —X-A (wherein X indicates a single... Agent: Birch Stewart Kolasch & Birch

20090275752 - Novel process for statins and its pharmaceutically acceptable salts thereof: Novel process for statins and its pharmaceutically acceptable salts thereof represented by general formula (I).... Agent: Hamilton, Brook, Smith & Reynolds, P.C.

20090275753 - Ortho-substituted aniline derivative and antioxidant drug: v

20090270615 - Method of preparing benzoxazines: This invention relates to a novel synthesis for the preparation of benzoxazine components from phenolic components, aldehyde components, and amine components in a solvent other than toluene.... Agent: Loctite Corporation

20090270616 - Aryl sulfonamides: Compounds are provided that act as potent antagonists of the CCR9 receptor, and which have been further confirmed in animal testing for inflammation, one of the hallmark disease states for CCR9. The compounds are generally aryl sulfonamide derivatives and are useful in pharmaceutical compositions, methods for the treatment of CCR9-mediated... Agent: Oblon, Spivak, Mcclelland Maier & Neustadt, L.L.P.

20090270617 - Phthalazinone derivative: 4-[3-(4-cyclopropanecarbonyl-piperazine-1-carbonyl)-4-fluoro-benzyl]-2H-phthalazin-1-one as crystalline Form A.... Agent: Michael Best & Friedrich LLP

20090270618 - Phosphonyl ester conjugates as prodrugs: Cidofovir or foscarnet based compounds having an amino acid or dipeptide esters are provided as prodrugs.... Agent: Gifford, Krass, Sprinkle,anderson & Citkowski, P.c

20090270619 - Method for producing alpha form crystals of sapropterin hydrochloride: A method for selectively producing stable alpha form crystals of sapropterin hydrochloride is provided. In this method, the alpha form crystal of sapropterin hydrochloride is produced by dissolving sapropterin hydrochloride with hydrochloric acid at a concentration of not less than 4 mol/L at not less than 70 degrees C.; adding... Agent: Oblon, Spivak, Mcclelland Maier & Neustadt, L.L.P.

20090270620 - Processes for preparing crystal forms of 9-hydroxy-risperidone (paliperidone): The present invention is related to processes for the preparation of paliperidone crystalline Form II. The invention also provides a paliperidone crystalline Form II containing isopropyl alcohol, and processes for preparing the same.... Agent: Kenyon & Kenyon LLP

20090270621 - Quinazoline analogs as receptor tyrosine kinase inhibitors: where an A group is bonded to at least one of the carbons at the 5, 6, 7 or 8 position of the bicyclic ring, and the ring is substituted by up to three independent R3 groups. The invention also includes methods of using these compounds as type I receptor... Agent: Mcdermott Will & Emery LLP

20090264650 - Prophylactic/therapeutic agent for diabetes: or a salt thereof, or a prodrug thereof. The 11β-hydroxysteroid dehydrogenase 1 inhibitor of the present invention has a superior activity, and is useful as a pharmaceutical agent such as agents for the prophylaxis or treatment of diabetes, insulin resistance, obesity, abnormal lipid metabolism, hypertension and the like, and the... Agent: Hogan & Hartson L.L.P.

20090264651 - Biological buffers with wide buffering ranges: Amines and amine derivatives that improve the buffering range, and/or reduce the chelation and other negative interactions of the buffer and the system to be buffered. The reaction of amines or polyamines with various molecules to form polyamines with differing pKa's will extend the buffering range, derivatives that result in... Agent: Clifford H. Kraft

20090264652 - Method for producing an amine: Processes comprising: (i) providing a reactant selected from the group consisting of primary alcohols, secondary alcohols, aldehydes, ketones and mixtures thereof; and (ii) reacting the reactant with hydrogen and a nitrogen compound selected from the group consisting of ammonia, primary amines, secondary amines and mixtures thereof in the presence of... Agent: Connolly Bove Lodge & Hutz, LLP

20090264653 - Useful indole compounds: Indoles that have activity as inhibitors of FAAH are described as are indoles and indole derivatives that have activity as inhibitors of DAO.... Agent: Fish & Richardson PC

20090264654 - Process for the preparation of pyrimidine compounds: A process for the preparation of a compound of Formula (1) and intermediates useful therein are provided. The process comprises reacting a compound of formula R1—CO—CH2-E with a compound of formula R2—CHX1X2 in the presence of a compound of formula R3R4N—C(═NH)NH2 and a catalyst, thereby to form a dihydropyrimidine; and... Agent: Morgan Lewis & Bockius LLP

20090264655 - Process for preparing 2,3-disubstituted indoles: p